Mesoblast (MESO) Dividends Paid - Common (2016 - 2023)

Mesoblast (MESO) posted Dividends Paid - Common of -$18.8 million for Q1 2023, down 5.24% sequentially from -$17.9 million in Q4 2022, and down 4.04% YoY from -$19.6 million in Q1 2022.

Mesoblast (MESO) Dividends Paid - Common (2016 - 2023) Analysis & Trends

Mesoblast has reported Dividends Paid - Common for 8 years, with the latest figure at -$18.8 million in Q1 2023.

  • Quarterly Dividends Paid - Common fell 4.04% year-over-year to -$18.8 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $32.5 million (down 41.34% YoY) and the FY2022 annual result came in at $60.4 million, down 55.84% from the prior year.
  • Dividends Paid - Common declined to -$18.8 million in Q1 2023 per MESO's latest filing, from -$17.9 million in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $116.0 million in Q3 2021 and troughed at -$30.6 million in Q4 2020.
  • A 5-year average of $20.5 million and a median of -$16.3 million in 2022 frame the typical range for Dividends Paid - Common.
  • The sharpest annual moves came in 2020 and 2021: Dividends Paid - Common plunged 220.49% in 2020, then soared 479.55% in 2021.
  • Over 5 years, Dividends Paid - Common stood at $46.8 million in 2019, then slumped by 165.36% to -$30.6 million in 2020, then jumped by 31.01% to -$21.1 million in 2021, then gained by 15.27% to -$17.9 million in 2022, then retreated by 5.24% to -$18.8 million in 2023.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered -$18.8 million, -$17.9 million, and $85.5 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 96.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 34.60 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Mesoblast 2.01 Bn 1.87 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 -18.82 Mn
Mar 31, 2023 -18.82 Mn
Dec 31, 2022 -17.88 Mn
Dec 31, 2022 -17.88 Mn
Sep 30, 2022 85.50 Mn
Sep 30, 2022 85.50 Mn
Jun 30, 2022 -16.31 Mn
Jun 30, 2022 -16.31 Mn
Mar 31, 2022 -18.09 Mn
Mar 31, 2022 -18.09 Mn
Dec 31, 2021 -21.11 Mn
Dec 31, 2021 -21.11 Mn
Sep 30, 2021 115.96 Mn
Sep 30, 2021 115.96 Mn
Jun 30, 2021 -21.38 Mn
Jun 30, 2021 -21.38 Mn
Mar 31, 2021 80.74 Mn
Mar 31, 2021 80.74 Mn
Dec 31, 2020 -30.60 Mn
Dec 31, 2020 -30.60 Mn